Document is current
Any future updates will be listed below
-
Authors
Frascatani, Rachele
Marafini, Irene
Colella, Marco
Monteleone, Giovanni
-
Funding
Funding for this research was provided by:
PRIN-2022 PNRR (P2022Y47YC)
PRIN HEAL ITALIA - PE6
- License Information
-
More Information
Article History
Received: 9 December 2025
Accepted: 2 February 2026
First Online: 9 February 2026
Declarations
:
: Giovanni Monteleone served as a consultant for First Wave BioPharma and Giuliani SpA and as a speaker for Takeda, Eli Lilly, Abbvie, Galapagos, and Pfizer and filed a patent related to the treatment of inflammatory bowel diseases with Smad7 antisense oligonucleotides. Irene Marafini served as a consultant and speaker for Abbvie, Eli Lilly and Galapagos.
